The Holistic prevention, management and treatment of Polycystic Ovarian Syndrome: The Antioxidants Bilirubin and Carotenoids

Weight Loss the Easy Ways
Andrea Albright Featured on Health and Fitness Jan. 2015
will Personally Coach You How to Get There The Easy Way

If You Are Looking For a SoulMate
Celebrity Patti Stanger Will Coach You To Get Him/Her
and Keep Him/Her for Good,The Simple Way

By Kyle J. Norton Health article writer and researcher; Over 10.000 articles and research papers have been written and published on line, including world wide health, ezine articles, article base, healthblogs, selfgrowth, best before it's news, the karate GB daily, etc.,.
Named TOP 50 MEDICAL ESSAYS FOR ARTISTS & AUTHORS TO READ by Disilgold.com Named 50 of the best health Tweeters Canada - Huffington Post
Nominated for shorty award over last 4 years
Some articles have been used as references in medical research, such as international journal Pharma and Bio science, ISSN 0975-6299.


                                         Polycystic Ovarian Syndrome

Polycystic Ovarian Syndrome is defined as endocrinologic diseases among reproductive-age women caused by undeveloped follicles clumping on the ovaries that interferes with the function of the normal ovaries associated with a high risk for metabolic disorder(1) as resulting of enlarged ovaries(2), leading to hormone imbalance(excessive androgen and anti-müllerian hormone (AMH) )(1)(3)(4)(5), induced Hirsutism(6)(7), reproductive disorder(10(12)), risks of type 2 diabetes(9)(10)(11), metabolic syndrome(10)(12) and early cardiovasular disease(8)(13), acne(10)(14), endometrial cance(18)(19),weight gain and obesity(15)(16)(17). The syndrome effects over 5% of women population or 1 in 20 women.
Unfortunately, according to studies, women with PCOs after the reproductive age, are associated to  continuously increase risk of type II diabetes, with no increasing altered glucose tolerance(20), CVD and hypertension(21).



                        The prevention and management 

Polycystic ovary syndrome (PCOS) is unpreventable in Western medicine. Early diagnosis and treatment  may reduce risk of its complications, including infertility, metabolic syndrome, obesity, diabetes, cardiovascular diseases, stroke, etc.

Although PCOS cannot be completely avoided, strengthening immunity has shown a significant reduction of chronic inflammatory diseases(266)(267)(268).


                     The Antioxidants
1. Bilirubin
Bilirubin is a prosthetic group helped to break down molecules into smaller units in releasing energy, excreted in bile and urine. It is a cellular antioxidant(511), by reverting to biliverdin, a green tetrapyrrolic bile pigment, once again when oxidized, it  inhibits the effects of mutagens(512). The antioxidant showed to inhibit digestive proteases like trypsin and chymotrypsin(504), benefit heart health(505) and nonalcoholic fatty liver disease(507), reduce risk of diabetes(506). Recent studies also found that the antioxidant exhibits its anti inflammatory effects(511) against certain chronic inflammatory diseases, including psoriasis(508), chronic obstructive pulmonary disease(509), .... and enhances immunity activities(510)

2. Carotenoids
Carotenoids are organic pigments, occurring in the chloroplasts and chromoplasts(513) of plants and some photosynthetic organisms like algae and bacteria(514).
a. Beta-carotene
Beta-carotene, an organic compound classified as a terpenoid, is a strongly-coloured red-orange pigment in plants and fruits, stored in liver for the production of vitamin A. Epidemiological evidences sugested that beta-carotene neutralizes singlet oxygen before giving rise of free radicals(515) which can damage of DNA, leading to improper cell DNA replication(516)(517), causing irregual cells growth, such as cancers(518)(519)(520). The phytochemical also promotes immunity(521)(522) against foreign invasion and symptoms of chronic inflammatory disease(523)(524) and improve low-density lipoprotein cholesterol resistance to oxidation causes of cardiovascular disease related to atherosclerosis(527) through its antioxidant anti inflammatory activities(525)(526).....

b. Alpha-carotene
Alpha-carotene, one of the most abundant carotenoids in the North American diet, is a form of carotene with a β-ring at one end and an ε-ring at the other, not only protects cells from the damaging effects of free radicals(526)  and enhances the immune system(528) in fighting against bacteria and virus infection and inflammation(529)(530), but also inhibits irregular cell growth(531)(532) cause of benign tumors(531) and cancers(532).

c. Beta-cryptoxanthin
Chemically Beta-cryptoxanthin is a xanthophyll which protects our cells from oxidation(538) and provides a source of vitamin A. The phytochemical showed to  enhances the immune system functioning(533)(534) against infectious(537) and inflammatory diseases(535)(536) and reduces insulin resistance(536) and cancers(539)(540) risks

d. Lycopene
Lycopene is a red carotene of the carotenoids group found in tomatoes, watermelons, and grapefruits. This antioxidant is believed to be a powerful fighter against irregular growth(543), such as prostate cancer(541)(542), breast cancer(544)(545) and liver diseases(546)(547). Lycopene has many anti-aging(549) capabilities as well as enhancing immune function(548) against oxidative stress(550)(551) and inflammatory diseases(551)(552).

Ovarian Cysts And PCOS Elimination
Holistic System In Existence That Will Show You How To
Permanently Eliminate All Types of Ovarian Cysts Within 2 Months   
 
References
(1) Adiposity and metabolic dysfunction in polycystic ovary syndrome by Sam S.(PubMed)
(2) A "kiss" before conception: triggering ovulation with kisspeptin-54 may improve IVF by Young SL.(PubMed)
(3.) Androgen hyperfunction and excessive heterosexual hair growth in women, with special attention to the polycystic ovarian syndrome by Lunde O¹.(PubMed)
(4) Expression of anti-Müllerian hormone in letrozole rat model of polycystic ovary syndrome by Du DF¹, Li XL, Fang F, Du MR.(PubMed)
(5) [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].[Article in Bulgarian] by Parahuleva N, Pehlivanov B, Orbecova M, Deneva T, Uchikova E.(PubMed)
(6) [Current opinions on the etiology and pathophysiology of hirsutism].[Article in Polish] by Krysiak R¹, Kedzia A, Okopień B.(PubMed)
(7) The clinical evaluation of hirsutism by Somani N¹, Harrison S, Bergfeld WF.(PubMed)
(8) Polycystic ovary syndrome and insulin: our understanding in the past, present and future by Mayer SB¹, Evans WS, Nestler JE.(PubMed)
(9) Association of mean platelet volume with androgens and insulin resistance in nonobese patients with polycystic ovary syndrome by Dogan BA¹, Arduc A², Tuna MM¹, Karakılıc E¹, Dagdelen I¹, Tutuncu Y¹, Berker D¹, Guler S¹.(PubMed)
(10) Approach to the patient: contraception in women with polycystic ovary syndrome by Yildiz BO¹.(PubMed)
(11) Polycystic ovarian syndrome (PCOS): a significant contributor to the overall burden of type 2 diabetes in women by Talbott EO¹, Zborowski JV, Rager JR, Kip KE, Xu X, Orchard TJ.(PubMed)
(12) Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities by Figurová J¹, Dravecká I, Javorský M, Petríková J, Lazúrová I.(PubMed)
(13) Role of Insulin Sensitizers on Cardiovascular Risk Factors in Polycystic Ovarian Syndrome: A Meta-Analysis by Thethi TK¹, Katalenich B², Nagireddy P³, Chabbra P⁴, Kuhadiya N⁵, Fonseca V¹.(PubMed)
(14) Acne in hirsute women by Lumezi BG¹, Pupovci HL¹, Berisha VL¹, Goçi AU², Gerqari A³.(PubMed)
(15) Obesity and polycystic ovary syndrome by Naderpoor N¹, Shorakae S, Joham A, Boyle J, De Courten B, Teede HJ.(PubMed)
(16) Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan by Teede H¹, Deeks A, Moran L.(PubMed)
(17) Metabolic Evidence of Diminished Lipid Oxidation in Women With Polycystic Ovary Syndrome. by Whigham LD¹, Butz DE², Dashti H³, Tonelli M³, Johnson LK¹, Cook ME², Porter WP⁴, Eghbalnia HR⁵, Markley JL⁶, Lindheim SR⁷, Schoeller DA⁸, Abbott DH⁹, Assadi-Porter FM¹⁰.(PubMed)
(18) Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis by Barry JA¹, Azizia MM¹, Hardiman PJ².(PubMed)
(19) Risk of cancer among women with polycystic ovary syndrome: a Danish cohort study by Gottschau M¹, Kjaer SK², Jensen A¹, Munk C¹, Mellemkjaer L³.(PubMed)
(20) Polycystic ovary syndrome: metabolic consequences and long-term management by Carmina E¹.(PubMed)
(21) Arterial stiffness is increased in asymptomatic nondiabetic postmenopausal women with a polycystic ovary syndrome phenotype by Armeni E¹, Stamatelopoulos K, Rizos D, Georgiopoulos G, Kazani M, Kazani A, Kolyviras A, Stellos K, Panoulis K, Alexandrou A, Creatsa M, Papamichael C, Lambrinoudaki I.(PubMed)
(266) [Immunopathological responses in women with chronic inflammatory diseases of the uterus and appendages and their therapeutic correction].[Article in Russian] by Medvedev BI¹, Kazachkova EA, Kazachkov EL.(PubMed)
(267) Cross Talk Between ER Stress, Oxidative Stress, and Inflammation in Health and Disease by Dandekar A¹, Mendez R, Zhang K.(PubMed)
(268) New dog and new tricks: evolving roles for IL-33 in type 2 immunity by Lott JM¹, Sumpter TL¹, Turnquist HR².(PubMed)
(507) Serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease by Kwak MS1, Kim D, Chung GE, Kang SJ, Park MJ, Kim YJ, Yoon JH, Lee HS.(PubMed)
(508) Antioxidant status in patients with psoriasis by Nemati H, Khodarahmi R, Sadeghi M, Ebrahimi A, Rezaei M, Vaisi-Raygani A.(PubMed)
(509) Serum Bilirubin and Disease Progression in Mild Chronic Obstructive Pulmonary Disease by Apperley S, Park HY, Holmes DT, Man SF, Tashkin D, Wise RA, Connett JE, Sin DD.(PubMed)(510) Cellular-mediated immune responses in the liver tissue of patients with severe Plasmodiumfalciparum malaria by Punsawadl C, Setthapramote C, Viriyavejakul P.(PubMed)
(511) Bile pigment pharmacokinetics and absorption in the rat: therapeutic potential for enteral administration by Bulmer AC1, Coombes JS, Blanchfield JT, Toth I, Fassett RG, Taylor SM.(PubMed)
(512) Bilirubin and related tetrapyrroles inhibit food-borne mutagenesis: a mechanism for antigenotoxic action against a model epoxide by Mölzer C1, Huber H, Steyrer A, Ziesel GV, Wallner M, Hong HT, Blanchfield JT, Bulmer AC, Wagner KH.(PubMed)
(513) Confocal laser scanning microscopy detection of chlorophylls and carotenoids in chloroplasts and chromoplasts of tomato fruit by D'Andrea L1, Amenós M, Rodríguez-Concepción M.(PubMed)
(514) Carotenoids(Wikipedia)
(515) Lycopene Inhibits the Isomerization of β-Carotene during Quenching of Singlet Oxygen and Free Radicals by Heymann T¹, Heinz P¹, Glomb MA¹.(PubMed)
(516) Wood smoke particles generate free radicals and cause lipid peroxidation, DNA damage, NFkappaB activation and TNF-alpha release in macrophages by Leonard SS¹, Wang S, Shi X, Jordan BS, Castranova V, Dubick MA.(PubMed)
(517) The Effects of Babesiosis on Oxidative Stress and DNA Damage in Anatolian Black Goats Naturally Infected with Babesia ovis by Kucukkurt I¹, Cigerci IH², Ince S³, Kozan E⁴, Aytekin I⁵, Eryavuz A⁶, Fidan AF¹.(PubMed)
(518) Beta-carotene and lung cancer in smokers: review of hypotheses and status of research by Goralczyk R¹.(PubMed)
(519) Beta-carotene in multivitamins and the possible risk of lung cancer among smokers versus former smokers: a meta-analysis and evaluation of national brands by Tanvetyanon T¹, Bepler G.(PubMed)
(520) Dietary Risk Reduction Factors for the Barrett's Esophagus-Esophageal Adenocarcinoma Continuum: A Review of the Recent Literature by Petrick JL¹, Li N¹, McClain KM¹, Steck SE², Gammon MD³.(PubMed)
(521) Short- and long-term beta-carotene supplementation do not influence T cell-mediated immunity in healthy elderly persons by Santos MS¹, Leka LS, Ribaya-Mercado JD, Russell RM, Meydani M, Hennekens CH, Gaziano JM, Meydani SN.(PubMed)
(522) A and beta-carotene concentrations in adults with HIV/AIDS on highly active antiretroviral therapy by Kaio DJ¹, Rondó PH, Souza JM, Firmino AV, Luzia LA, Segurado AA.(PubMed)
(523) Plasma antioxidant levels in chronic cholestatic liver diseases by Floreani A¹, Baragiotta A, Martines D, Naccarato R, D'odorico A.(PubMed)
(524) Use of antioxidants to treat pain in chronic pancreatitis.[Article in English, Spanish by De las Heras Castaño G¹, García de la Paz A, Fernández MD, Fernández Forcelledo JL.(PubMed)
(525) Functional nutraceutical profiling of wild edible and medicinal mushrooms consumed by ethnic tribes in India by Khaund P¹, Joshi SR¹.(PubMed)
(526)Dietary intake of carotenoids and their antioxidant and anti-inflammatory effects in cardiovascular cares. by Ciccone MM¹, Cortese F¹, Gesualdo M¹, Carbonara S¹, Zito A¹, Ricci G¹, De Pascalis F¹, Scicchitano P¹, Riccioni G².(PubMed)
(527) Carotenoids and cardiovascular risk by Giordano P¹, Scicchitano P, Locorotondo M, Mandurino C, Ricci G, Carbonara S, Gesualdo M, Zito A, Dachille A, Caputo P, Riccardi R, Frasso G, Lassandro G, Di Mauro A, Ciccone MM.(PubMed)
(528) Supplementation of a low-carotenoid diet with tomato or carrot juice modulates immune functions in healthy men by Watzl B¹, Bub A, Briviba K, Rechkemmer G.(PubMed)
(529) Nutritional biomarkers associated with gynecological conditions among US women with or at risk of HIV infection by Tohill BC¹, Heilig CM, Klein RS, Rompalo A, Cu-Uvin S, Piwoz EG, Jamieson DJ, Duerr A.(PubMed)
(530) Low levels of plasma carotenoids are associated with an increased risk of atrial fibrillation by Karppi J¹, Kurl S, Mäkikallio TH, Ronkainen K, Laukkanen JA.(PubMed)
(531)Adolescent carotenoid intake and benign breast disease by Boeke CE¹, Tamimi RM², Berkey CS³, Colditz GA⁴, Eliassen AH², Malspeis S⁵, Willett WC⁶, Frazier AL⁷.(PubMed)
(532) Dietary carotenoids and risk of breast cancer in Chinese women by Huang JP¹, Zhang M, Holman CD, Xie X.(PubMed)
(533) Effect of carotenoid β-cryptoxanthin on cellular and humoral immune response in rabbit by Ghodratizadeh S¹, Kanbak G, Beyramzadeh M, Dikmen ZG, Memarzadeh S, Habibian R.(PubMed)
(534) beta-Carotene and beta-cryptoxanthin but not lutein evoke redox and immune changes in RAW264 murine macrophages by Katsuura S¹, Imamura T, Bando N, Yamanishi R.(PubMed)
(535) β-Cryptoxanthin alleviates diet-induced nonalcoholic steatohepatitis by suppressing inflammatory gene expression in mice by Kobori M¹, Ni Y², Takahashi Y¹, Watanabe N¹, Sugiura M³, Ogawa K⁴, Nagashimada M⁵, Kaneko S⁶, Naito S¹, Ota T².(PubMed)
(536) Prevention and reversal of lipotoxicity-induced hepatic insulin resistance and steatohepatitis in mice by an antioxidant carotenoid, β-cryptoxanthin by Ni Y¹, Nagashimada M, Zhan L, Nagata N, Kobori M, Sugiura M, Ogawa K, Kaneko S, Ota T.(PubMed)
(537) The role of diet and nutrition in cervical carcinogenesis: a review of recent evidence by García-Closas R¹, Castellsagué X, Bosch X, González CA.(PubMed)
(538) The carotenoid beta-cryptoxanthin stimulates the repair of DNA oxidation damage in addition to acting as an antioxidant in human cells by Lorenzo Y¹, Azqueta A, Luna L, Bonilla F, Domínguez G, Collins AR.(PubMed)
(539) Antiproliferative activity of Cyanophora paradoxa pigments in melanoma, breast and lung cancer cells by Baudelet PH¹, Gagez AL, Bérard JB, Juin C, Bridiau N, Kaas R, Thiéry V, Cadoret JP, Picot L.(PubMed)
(540) Dietary carotenoids and risk of breast cancer in Chinese women by Huang JP¹, Zhang M, Holman CD, Xie X.(PubMed)
(541) Lycopene/tomato consumption and the risk of prostate cancer: a systematic review and meta-analysis of prospective studies by Chen J¹, Song Y, Zhang L.(PubMed)
(542) The role of tomato products and lycopene in the prevention of prostate cancer: a meta-analysis of observational studies by Etminan M¹, Takkouche B, Caamaño-Isorna F.(PubMed)
(543) The anti-cancer effects of carotenoids and other phytonutrients resides in their combined activity by Linnewiel-Hermoni K¹, Khanin M¹, Danilenko M¹, Zango G¹, Amosi Y¹, Levy J¹, Sharoni Y².(PubMed)
(544) Inhibitory effects of combination of lycopene and genistein on 7,12- dimethyl benz(a)anthracene-induced breast cancer in rats by Sahin K¹, Tuzcu M, Sahin N, Akdemir F, Ozercan I, Bayraktar S, Kucuk O.(PubMed)
(545) Lycopene and beta-carotene induce cell-cycle arrest and apoptosis in human breast cancer cell lines by Gloria NF¹, Soares N, Brand C, Oliveira FL, Borojevic R, Teodoro AJ.(PubMed)
(546) Non-alcoholic steatohepatitis and hepatocellular carcinoma: implications for lycopene intervention by Ip BC¹, Wang XD².(PubMed)
(547) Lipid biomarkers and metabolic effects of lycopene from tomato juice on liver of rats with induced hepatic steatosis by Bernal C¹, Martín-Pozuelo G, Lozano AB, Sevilla A, García-Alonso J, Canovas M, Periago MJ.(PubMed)
(548) Lycopene enhances antioxidant enzyme activities and immunity function in N-methyl-N'-nitro-N-nitrosoguanidine-enduced gastric cancer rats by Luo C¹, Wu XG.(PubMed)
(549) Anti-aging effect of Blakeslea trispora powder on adult mice by Hu W¹, Dai D, Li W.(PubMed)
(550) The effects of lycopene on DNA damage and oxidative stress on indomethacin-induced gastric ulcer in rats by Boyacioglu M¹, Kum C², Sekkin S², Yalinkilinc HS², Avci H³, Epikmen ET³, Karademir U².(PubMed)
(551) Beneficial effect of lycopene on anti-diabetic nephropathy through diminishing inflammatory response and oxidative stress by Guo Y¹, Liu Y, Wang Y.(PubMed)
(552) Nrf2, a master regulator of detoxification and also antioxidant, anti-inflammatory and other cytoprotective mechanisms, is raised by health promoting factors by Pall ML¹, Levine S².(PubMed)